Vanessa Riveiro

ORCID: 0000-0003-2654-5482
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • Intensive Care Unit Cognitive Disorders
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms
  • Obstructive Sleep Apnea Research
  • Neuroscience of respiration and sleep
  • Pleural and Pulmonary Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pneumothorax, Barotrauma, Emphysema
  • Infectious Diseases and Tuberculosis
  • Thermal Regulation in Medicine
  • COVID-19 and Mental Health
  • Drug-Induced Adverse Reactions
  • Dysphagia Assessment and Management
  • Family and Patient Care in Intensive Care Units
  • Myasthenia Gravis and Thymoma
  • Patient Satisfaction in Healthcare
  • Cardiovascular and Diving-Related Complications
  • Inhalation and Respiratory Drug Delivery
  • Cystic Fibrosis Research Advances
  • Airway Management and Intubation Techniques
  • Hematological disorders and diagnostics
  • Multiple Myeloma Research and Treatments
  • Sarcoidosis and Beryllium Toxicity Research
  • Cardiovascular Syncope and Autonomic Disorders

Complejo Hospitalario Universitario de Santiago
2017-2024

Universidade de Santiago de Compostela
2020-2024

Instituto de Investigación Sanitaria de Santiago
2020-2022

Low-dose dexamethasone demonstrated clinical improvement in patients with coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the efficacy of high-dose is limited.We performed a randomised, open-label, controlled trial involving hospitalised confirmed COVID-19 pneumonia therapy. Patients were randomly assigned 1:1 ratio to receive low-dose (6 mg once daily for 10 days) or (20 5 days, followed by an additional days). The primary outcome was worsening within 11...

10.1183/13993003.02518-2021 article EN cc-by-nc European Respiratory Journal 2021-12-16

Abstract The prognosis of a patient with COVID-19 pneumonia is uncertain. Our objective was to establish predictive model disease progression facilitate early decision-making. A retrospective study performed patients admitted pneumonia, classified as severe (admission the intensive care unit, mechanic invasive ventilation, or death) non-severe. based on clinical, laboratory, and radiological parameters built. probability estimated by logistic regression analysis. Calibration discrimination...

10.1038/s41598-020-75651-z article EN cc-by Scientific Reports 2020-11-13

This study assesses the impact of an electronic physician-to-physician consultation program on waiting list and costs a Pulmonology Unit.A prepost intervention was conducted after new ambulatory pulmonary care protocol implemented capacity unit adopted. In model, physicians at all levels healthcare send consultations to specialists.In preintervention year (2019), Unit attended 7,055 (466 e-consultations 6,589 first face-to-face visits), which decreased 6,157 (3,934 2,223 visits; 12.7%...

10.1155/2022/2423272 article EN cc-by Canadian Respiratory Journal 2022-10-31

Abstract Introduction Inhaled antibiotics reduce the frequency of exacerbations. The objective was to assess efficacy inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis (NCFB) and concomitant chronic bronchial infection (CBI) caused by potentially pathogenic microorganisms (PPM) other than Pseudomonas aeruginosa (PA). Material Method Quasi‐experimental study 21 exacerbations who developed CBI a PPM PA. Results Bacterial resolved 85.7% patients. Rehospitalizations, length...

10.1111/crj.13534 article EN The Clinical Respiratory Journal 2022-08-26

Background The diagnostic criteria for Hypersensitivity pneumonitis (HP) have changed over time. Our aim is to apply a recent algorithm historical series of patients diagnosed with HP assess its distribution according current and the confidence achieved.

10.1080/17476348.2024.2358939 article EN Expert Review of Respiratory Medicine 2024-04-02

Background The definitive etiology of nonspecific pleuritis (NSP), the influence type pleural biopsy on clinical results and minimum duration follow-up is controversial.

10.1080/17476348.2024.2368610 article EN Expert Review of Respiratory Medicine 2024-05-03

Ana Casal-Mouriño, José Manuel Álvarez-Dobaño, María Jesús Domínguez, Francisco Gude, E. Toubes, Óscar Lado-Baleato, Anxo Martínez de Alegría, Taboada, Vanessa Riveiro, Nuria Rodríguez-Núñez, Adriana Lama, Lucía Ferreiro, Borja Otero, Juan Suárez-Antelo, Antonio Pose, Luis Valdés

10.21037/jtd-22-1565 article EN Journal of Thoracic Disease 2023-04-27
Coming Soon ...